Molecular, AI, And HPV: Cervical Cancer Detection Evolved
*Corresponding Author: Dr. William Carter, University of Melbourne, Australia, Email: william.carter@rediffmail.comReceived Date: Jun 04, 2025 / Published Date: Jun 30, 2025
Citation: Carter DW (2025) Molecular, AI, And HPV: Cervical Cancer Detection Evolved. Current Trends Gynecol Oncol 10: 281
Copyright: 漏 2025 Dr. William Carter This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
This compilation examines the evolving landscape of cervical cancer detection. It highlights the transition to molecular methods like HPV DNA testing as a primary screening tool and the application of artificial intelligence in image analysis for colposcopy and cytology. The role of next-generation sequencing in biomarker discovery, the efficacy of HPV self-sampling for increased participation, and the development of non-invasive biomarkers are discussed. Risk-based screening strategies and the performance of various HPV testing platforms are also reviewed, underscoring the ongoing progress towards more accurate and accessible cervical cancer early detection.

